alanyl-glutamyl-aspartyl-glycine and Diabetes Mellitus, Type 2

alanyl-glutamyl-aspartyl-glycine has been researched along with Diabetes Mellitus, Type 2 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Khavinson, VKh; Romashevskiĭ, BV; Shustov, SB; Shutak, TS	1

Other Studies

1 other study(ies) available for alanyl-glutamyl-aspartyl-glycine and Diabetes Mellitus, Type 2

Article	Year
[Epithalamin effects on carbohydrate metabolism and cardiovascular system in patients with non-insulin dependent diabetes mellitus]. Klinicheskaia meditsina, 1998, Volume: 76, Issue:9 Topics: Antineoplastic Agents; Carbohydrates; Cardiovascular System; Diabetes Mellitus, Type 2; Echocardiography, Doppler; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Injections, Intramuscular; Insulin; Male; Middle Aged; Peptides; Pineal Gland; Treatment Outcome; Ventricular Function, Left	1998

Article

Year

[Epithalamin effects on carbohydrate metabolism and cardiovascular system in patients with non-insulin dependent diabetes mellitus].

Klinicheskaia meditsina, 1998, Volume: 76, Issue:9

Topics: Antineoplastic Agents; Carbohydrates; Cardiovascular System; Diabetes Mellitus, Type 2; Echocardiography, Doppler; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Injections, Intramuscular; Insulin; Male; Middle Aged; Peptides; Pineal Gland; Treatment Outcome; Ventricular Function, Left

1998